Geneva, June 4 -- International Clinical Trials Registry received information related to the study (TCTR20250522003) titled 'A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Nebivolol 5 mg Tablets and Reference Product (NEBILET) in Healthy Thai Volunteers under Fasting Conditions' on May 22.
Study Type: Interventional
Study Design:
Randomized
Primary Sponsor: International Bio Service Co., Ltd.
Condition:
Bioequivalence study in healthy Thai male volunteers
Bioequivalence Study of Generic Nebivolol 5 mg Tablets and Reference Product (NEBILET) in Healthy Thai Volunteers under Fasting Conditions
Bioequivalence Study of Generic Nebivolol 5 mg Tablets and Reference Product (NEBILET) in Healthy Th...